Time for a change in drug licensing requirements?-Reference-Cited by-同舟云学术

Time for a change in drug licensing requirements?

Published:2002-06 Issue:2 Volume:3 Page:137-138
ISSN:1618-7598
Container-title:The European Journal of Health Economics
language:en
Short-container-title:Eur J Health Econom

Author:

Drummond Michael F.

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics, Econometrics and Finance (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s10198-002-0119-4.pdf

Reference3 articles.

1. Freemantle N,Henry D,Maynard A,Torrance G (1995) Promoting cost-effective prescribing: Great Britain lags behind. British Medical Journal; 310: 955–956

2. Drummond M F, Jefferson T O (1996) for the BMJ Economic Evaluation Working Party. Guidelines for authors and peer reviewers of economic submissions to the BMJ. British Medical Journal; 313: 275–283

3. Commonwealth of Australia (1995) Guidelines for submissions to the Pharmaceutical Benefits Advisory Committee: including economic analysis. Department of Health and Community Services,Canberra

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new prize system for drug innovation;Health Policy;2011-10

2. Progression: Things We Need to Remember but Often Forget to Think About;Optometry and Vision Science;2008-06

3. La financiación y la regulación del precio de los medicamentos en el Sistema Nacional de Salud: cambios y continuidad;Gaceta Sanitaria;2007-01

4. Collection of Health-Economic Data Alongside Clinical Trials: Is There a Future for Piggyback Evaluations?;Value in Health;2005-01

5. Issues for countries considering introducing the “fourth hurdle”: The case of Hungary;International Journal of Technology Assessment in Health Care;2004-08